+13.1%
GSK vs CPB
-18.4%
+31.6%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CPB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +5.9% | -0.9% | +3.8% |
| 7D | +4.9% | +13.0% | -8.0% | +2.5% |
| 30D | +9.9% | +20.5% | -10.6% | +6.0% |
| 3M | +0.2% | +2.2% | -2.0% | -1.0% |
| 6M | +2.3% | +15.4% | -13.1% | -0.8% |
| YTD | +7.1% | -12.3% | +19.4% | +8.1% |
| 1Y | +13.1% | -18.0% | +31.1% | +15.9% |
| All | +13.1% | -18.4% | +31.6% | +15.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CPB.
Daily Out/Under-Performance
Portfolio return minus CPB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CPB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CPB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling